Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advance Solid Tumors”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Early research (Phase 1)Looking for participantsNCT05238792
What this trial is testing

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Who this might be right for
Solid Tumor
Children's National Research Institute 24
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Early research (Phase 1)Ended earlyNCT01137552
What this trial is testing

Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 44
Early research (Phase 1)Study completedNCT01582997
What this trial is testing

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors

Who this might be right for
Cancer
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Early research (Phase 1)Study completedNCT01905228
What this trial is testing

Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

Who this might be right for
Solid TumorsGlioblastoma
Incuron 83
Early research (Phase 1)Study completedNCT01653158
What this trial is testing

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Who this might be right for
Advanced Non-Hematologic Malignancies
Pfizer 46
Early research (Phase 1)Study completedNCT00731263
What this trial is testing

Tor Kinase Inhibitor in Advanced Tumors

Who this might be right for
Solid Tumors
AstraZeneca 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557449
What this trial is testing

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Who this might be right for
LiposarcomaProstate CancerBreast Neoplasms+1 more
Pfizer 362
Testing effectiveness (Phase 2)Looking for participantsNCT07610798
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Who this might be right for
Advance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more
Shenzhen Ionova Life Sciences Co., Ltd. 178
Testing effectiveness (Phase 2)Study completedNCT03035591
What this trial is testing

ODM-207 in Patients With Advance Solid Tumours

Who this might be right for
Solid Tumors
Orion Corporation, Orion Pharma 36
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableLooking for participantsNCT04242095
What this trial is testing

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmImmune System DisorderMalignant Solid Neoplasm
Alliance for Clinical Trials in Oncology 2,240
Early research (Phase 1)Study completedNCT00426140
What this trial is testing

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Who this might be right for
Advanced MalignanciesSolid Tumors
Novartis Pharmaceuticals 5
Not applicableStudy completedNCT01817686
What this trial is testing

Study of Default Options in Advance Directives

Who this might be right for
COPDSevere or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen TherapyIdiopathic Pulmonary Fibrosis+5 more
Corporal Michael J. Crescenz VA Medical Center 62
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Early research (Phase 1)Study completedNCT00997945
What this trial is testing

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 15
Early research (Phase 1)Looking for participantsNCT07639047
What this trial is testing

An Initial Evaluation of AN8025 in Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)
Adlai Nortye Biopharma Co., Ltd. 91
Not applicableLooking for participantsNCT07141407
What this trial is testing

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Next Page